$TZYM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ocera Therapeutics, Inc.. Get notifications about new insider transactions in Ocera Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2017 | TZYM | Ocera Therapeutics ... | DOMAIN ASSOCIATES | 10% Owner | Sell | D | 0.00 | 47,963 | 0 | 0 | 48 K to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | DP VI Associates, L.P. | 10% Owner | Sell | D | 0.00 | 15,731 | 0 | 0 | 15.7 K to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VI, L.P. | 10% Owner | Option Exercise | D | 0.67 | 20,150 | 13,501 | 0 | |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VI, L.P. | 10% Owner | Option Exercise | D | 0.67 | 20,150 | 13,501 | 0 | |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VI, L.P. | 10% Owner | Sell | D | 0.00 | 1,857,036 | 0 | 0 | 1.9 M to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | DP VIII Associates, L.P. | 10% Owner | Sell | D | 0.00 | 7,333 | 0 | 0 | 7.3 K to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VIII, L.P. | 10% Owner | Sell | D | 0.00 | 988,285 | 0 | 0 | 988.3 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 11,969 | 8,019 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 30,827 | 20,654 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 30,826 | 20,653 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 7.84 | 37,500 | 294,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 7.38 | 491,550 | 3,627,639 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 3.76 | 160,000 | 601,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 2.98 | 348,600 | 1,038,828 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 2.15 | 289,200 | 621,780 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Sell | D | 1.52 | 70,000 | 106,400 | 0 | 70 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Sell | D | 1.52 | 230,000 | 349,600 | 0 | 230 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | D | 2.15 | 208,350 | 447,953 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | D | 3.06 | 300,000 | 918,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Sell | D | 1.52 | 200,000 | 304,000 | 0 | 200 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Sell | D | 1.52 | 2,500 | 3,800 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 5.51 | 20,000 | 110,200 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 7.50 | 70,000 | 525,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 2.15 | 102,300 | 219,945 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 3.76 | 75,000 | 282,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 7.50 | 55,000 | 412,500 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 2.98 | 123,300 | 367,434 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Sell | D | 1.52 | 150,000 | 228,000 | 0 | 150 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Sell | D | 1.52 | 13,000 | 19,760 | 0 | 13 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Dere Willard H | Director | Option Exercise | D | 2.43 | 20,000 | 48,500 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Dere Willard H | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 50.88 | 2,652 | 134,934 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 48.00 | 2,083 | 99,984 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 1.84 | 2,992 | 5,505 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 1.84 | 2,992 | 5,505 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Sell | D | 1.52 | 11,969 | 18,193 | 0 | 12 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Sell | D | 1.52 | 344,719 | 523,973 | 0 | 344.7 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 13.25 | 20,000 | 265,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Sell | D | 1.52 | 5,000 | 7,600 | 0 | 5 K to 0 (-100.00 %) |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | Dere Willard H | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Grant | A | 0.00 | 12,500 | 0 | 17,500 | 5 K to 17.5 K (+250.00 %) |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Mar 30 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Grant | A | 0.00 | 150,000 | 0 | 163,000 | 13 K to 163 K (+1,153.85 %) |
Mar 30 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Grant | A | 0.00 | 200,000 | 0 | 202,500 | 2.5 K to 202.5 K (+8,000.00 %) |
Mar 30 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Grant | A | 0.00 | 230,000 | 0 | 300,000 | 70 K to 300 K (+328.57 %) |
Mar 28 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Buy | P | 1.28 | 3,000 | 3,854 | 13,000 | 10 K to 13 K (+30.00 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | X | 0.67 | 125 | 84 | 0 | |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | X | 0.67 | 125 | 84 | 0 | |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | X | 0.67 | 1,820 | 1,219 | 0 | |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | X | 0.67 | 1,820 | 1,219 | 0 | |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | X | 0.67 | 9,187 | 6,155 | 0 | |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | X | 0.67 | 9,187 | 6,155 | 0 | |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Buy | J | 0.00 | 14,328 | 0 | 14,328 | 0 to 14.3 K |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | J | 0.00 | 9,540 | 0 | 0 | 9.5 K to 0 (-100.00 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | J | 0.00 | 138,686 | 0 | 0 | 138.7 K to 0 (-100.00 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | J | 0.00 | 699,996 | 0 | 0 | 700 K to 0 (-100.00 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | S | 2.29 | 74 | 170 | 9,540 | 9.6 K to 9.5 K (-0.77 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | S | 2.29 | 1,066 | 2,443 | 138,686 | 139.8 K to 138.7 K (-0.76 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | S | 2.29 | 5,372 | 12,313 | 699,996 | 705.4 K to 700 K (-0.76 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Buy | X | 0.67 | 250 | 168 | 9,614 | 9.4 K to 9.6 K (+2.67 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Buy | X | 0.67 | 3,640 | 2,439 | 139,752 | 136.1 K to 139.8 K (+2.67 %) |
Dec 30 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Buy | X | 0.67 | 18,374 | 12,311 | 705,368 | 687 K to 705.4 K (+2.67 %) |
Dec 16 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 2.15 | 289,200 | 621,780 | 289,200 | |
Dec 16 2016 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | A | 2.15 | 102,300 | 219,945 | 102,300 | |
Dec 16 2016 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | A | 2.15 | 208,350 | 447,953 | 208,350 | |
Dec 08 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 2.14 | 7,000 | 14,980 | 70,000 | 63 K to 70 K (+11.11 %) |
Oct 28 2016 | TZYM | Ocera Therapeutics ... | Dere Willard H | Director | Option Exercise | A | 2.42 | 20,000 | 48,400 | 20,000 | |
Oct 17 2016 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Buy | P | 2.64 | 2,500 | 6,598 | 2,500 | 0 to 2.5 K |
Jul 13 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | M | 1.26 | 11,969 | 15,081 | 0 | |
Jul 13 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Buy | M | 1.26 | 11,969 | 15,081 | 11,969 | 0 to 12 K |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
Mar 07 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 3.19 | 3,000 | 9,570 | 63,000 | 60 K to 63 K (+5.00 %) |
Jan 25 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 2.38 | 10,000 | 23,800 | 60,000 | 50 K to 60 K (+20.00 %) |
Jan 19 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 2.08 | 10,000 | 20,800 | 50,000 | 40 K to 50 K (+25.00 %) |
Jan 19 2016 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Buy | P | 2.07 | 3,500 | 7,245 | 10,000 | 6.5 K to 10 K (+53.85 %) |
Jan 19 2016 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Buy | P | 2.15 | 10,000 | 21,500 | 20,000 | 10 K to 20 K (+100.00 %) |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | A | 3.06 | 100,000 | 306,000 | 100,000 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | A | 3.06 | 300,000 | 918,000 | 300,000 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | A | 2.98 | 41,100 | 122,478 | 41,100 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | A | 2.98 | 123,300 | 367,434 | 123,300 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Option Exercise | A | 2.98 | 49,325 | 146,989 | 49,325 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Option Exercise | A | 2.98 | 147,975 | 440,966 | 147,975 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 2.98 | 116,200 | 346,276 | 116,200 | |
Jan 07 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 2.98 | 348,600 | 1,038,828 | 348,600 | |
Jan 06 2016 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | M | 0.92 | 11,969 | 11,011 | 0 | |
Jan 06 2016 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Gift | G | 0.00 | 11,969 | 0 | 344,719 | 356.7 K to 344.7 K (-3.36 %) |
Jan 06 2016 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Buy | M | 0.92 | 11,969 | 11,011 | 356,688 | 344.7 K to 356.7 K (+3.47 %) |
Jun 24 2015 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Buy | P | 3.71 | 5,000 | 18,550 | 5,000 | 0 to 5 K |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 3.76 | 160,000 | 601,600 | 160,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | A | 3.76 | 75,000 | 282,000 | 75,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Option Exercise | A | 3.76 | 75,000 | 282,000 | 75,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
May 07 2015 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Buy | P | 3.97 | 5,050 | 20,049 | 5,050 | 0 to 5.1 K |
May 06 2015 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 3.73 | 30,000 | 111,900 | 40,000 | 10 K to 40 K (+300.00 %) |
May 06 2015 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Buy | P | 3.61 | 2,500 | 9,025 | 6,500 | 4 K to 6.5 K (+62.50 %) |
May 06 2015 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Buy | P | 3.62 | 7,500 | 27,150 | 10,000 | 2.5 K to 10 K (+300.00 %) |
Dec 04 2014 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | A | 7.50 | 70,000 | 525,000 | 70,000 | |
Oct 02 2014 | TZYM | Ocera Therapeutics ... | Byrnes Michael | VP, Finance & Treas ... | Buy | P | 4.81 | 2,000 | 9,620 | 4,000 | 2 K to 4 K (+100.00 %) |
Sep 18 2014 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | A | 5.51 | 20,000 | 110,200 | 20,000 | |
Sep 02 2014 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Option Exercise | A | 6.03 | 20,000 | 120,600 | 20,000 | |
Sep 02 2014 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Option Exercise | A | 6.03 | 20,000 | 120,600 | 20,000 | |
Sep 02 2014 | TZYM | Ocera Therapeutics ... | Patni Rajiv | Chief Development O ... | Option Exercise | A | 6.03 | 250,000 | 1,507,500 | 250,000 | |
Jul 15 2014 | TZYM | Ocera Therapeutics ... | TETLOW SHARON | Acting CFO & Treasu ... | Buy | P | 5.83 | 3,000 | 17,487 | 3,000 | 0 to 3 K |
Jul 15 2014 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 5.93 | 10,000 | 59,280 | 10,000 | 0 to 10 K |
Jun 20 2014 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | Grais Linda S | President & CEO | Option Exercise | A | 7.84 | 75,000 | 588,000 | 75,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | Castaigne Jean-Paul | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Option Exercise | A | 7.84 | 25,000 | 196,000 | 25,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
Jun 13 2014 | TZYM | Ocera Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 7.84 | 10,000 | 78,400 | 10,000 | |
May 02 2014 | TZYM | Ocera Therapeutics ... | Aggarwal Gaurav | Chief Business Offi ... | Option Exercise | A | 8.26 | 175,000 | 1,445,500 | 175,000 | |
Mar 20 2014 | TZYM | Ocera Therapeutics ... | POWELL MICHAEL | Director | Sell | J | 0.00 | 4,612 | 0 | 9,364 | 14 K to 9.4 K (-33.00 %) |